← Back to Search

Healthy Liver/Hígado Sano program for Non-alcoholic Fatty Liver Disease

N/A

Waitlist Available

Led By Natalia I Heredia, PhD

Research Sponsored by The University of Texas Health Science Center, Houston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 6 months after enrollment

Awards & highlights

Study Summary

This trial will test a lifestyle intervention for Hispanic/Latino patients with NAFLD to see if it is effective.

Eligible Conditions

Non-alcoholic Fatty Liver Disease

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 6 months after enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 6 months after enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months after enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Intervention group participants Satisfaction of program as assessed by the Client Satisfaction Questionnaire (CSQ-8)

Number of participants recruited

Number of participants that adhere to the intervention

+1 more

Secondary outcome measures

Change in Anxiety as assessed by the 7-item Generalized Anxiety Disorder (GAD-7) questionnaire.

Change in Depression as assessed by the 10-item Center for Epidemiologic Studies Depression Scale (CESD-10)

Change in Perceived treatment efficacy

+14 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Healthy Liver/Hígado Sano programExperimental Treatment1 Intervention

Group II: Control GroupActive Control1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Healthy Liver/Hígado Sano program

2022

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor

903 Previous Clinical Trials

320,950 Total Patients Enrolled

3 Trials studying Non-alcoholic Fatty Liver Disease

103 Patients Enrolled for Non-alcoholic Fatty Liver Disease

Prevent Cancer FoundationOTHER

5 Previous Clinical Trials

507 Total Patients Enrolled

Natalia I Heredia, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available positions in this clinical trial?

"The information available on clinicaltrials.gov demonstrates that this trial is presently in the process of recruiting subjects. It was initially listed on May 11th 2022 and last updated six days later, on May 16th 2022."

Answered by AI

What population size is being targeted for participation in this research endeavor?

"Affirmative. Information located on clinicaltrials.gov reveals that recruitment is underway for this medical trial, which was first listed on the 11th of May 2022 and most recently updated 6 days later. 30 individuals are being sought after at a single medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pilot of Lifestyle Behavior Intervention for Non-Alcoholic Fatty Liver Disease

Natalia Heredia 2022. "Pilot of Lifestyle Behavior Intervention for Non-Alcoholic Fatty Liver Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05200585.